Get the Stockscreener App
11.57
4.06%
-0.49
Wave Life Sciences Ltd Stock (WVE) Forecast
The Wave Life Sciences Ltd (WVE) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $11.47, representing a -0.91% decrease from the current price of $11.57. The highest analyst price target is $11.58, and the lowest is $11.35.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month WVE Price Target
Average 7.6975
(-33.47% Downside)
Is Wave Life Sciences Ltd (WVE) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 41.66 | Neutral |
| STOCH(9,6) | 66.69 | Neutral |
| STOCHRSI(14) | 57.82 | Neutral |
| MACD(12,26) | -0.3691 | Buy |
| ADX(14) | 11.89 | Neutral |
| William %R | -48.45 | Neutral |
| CCI(14) | 6.2611 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
11.75
Sell
|
11.85
Sell
|
| MA20 |
11.98
Sell
|
12.08
Sell
|
| MA50 |
13.22
Sell
|
12.49
Sell
|
| MA100 |
11.99
Sell
|
11.66
Sell
|
| MA200 |
8.852
Buy
|
9.8578
Buy
|
Buy: 2
Sell: 8
Neutral: 0
Summary: Sell
According to our latest analysis, WVE could be considered a Moderate Sell, with 17 technical analysis indicators signaling 3 Buy signals, 8 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on WVE, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 41.66 indicates that WVE is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 66.69 indicates that WVE is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 57.82 indicates that WVE is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 11.89 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 6.2611 indicates that WVE is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term WVE price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Wave Life Sciences Ltd financial reports and earnings history, Wave Life Sciences Ltd (WVE) stock could reach $18.55 by 2030, $20.25 by 2040 and $58.36 by 2050. See the projected annual prices until 2050 of the Wave Life Sciences Ltd stock below:
- Wave Life Sciences Ltd (WVE) is expected to reach an average price of $6.9953 in 2035, with a high prediction of $7.2671 and a low estimate of $7.2353. This indicates an $-39.54% rise from the last recorded price of $11.57.
- Wave Life Sciences Ltd (WVE) stock is projected to chart a bullish course in 2040, with an average price target of $20.48, representing an $77.04% surge from its current level. The forecast ranges from a conservative $20.40 to a sky-high $20.25.
- Our analysts predict Wave Life Sciences Ltd (WVE) to jump 214.05% by 2045, soaring from $37.06 to an average price of $36.34, potentially reaching $37.48. While $37.06 is the low estimate, the potential upside is significant.
- Wave Life Sciences Ltd (WVE) stock is expected to climb by 2050, reaching an average of $57.80, a $399.57% jump from its current level. However, a wide range of estimates exists, with high and low targets of $58.36 and $58.21, respectively, highlighting the market's uncertainty.
Wave Life Sciences Ltd Stock (WVE) Year by Year Forecast
Wave Life Sciences Ltd Stock (WVE) Price Forecast for 2025
Wave Life Sciences Ltd Stock (WVE) is expected to reach an average price of $11.97 in 2025, with a high prediction of $20.13 and a low estimate of $3.811. This indicates an +3.46% rise from the last recorded price of $11.57.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $10.98 | $11.35 | $11.58 | -5.12% |
| April, 2025 | $9.5823 | $10.17 | $9.8692 | -17.18% |
| May, 2025 | $10.46 | $10.57 | $10.34 | -9.63% |
| June, 2025 | $7.9805 | $10.27 | $9.6684 | -31.02% |
| July, 2025 | $7.3056 | $8.2925 | $7.9536 | -36.86% |
| August, 2025 | $7.9197 | $7.6666 | $7.4847 | -31.55% |
| September, 2025 | $8.4438 | $8.2007 | $8.4138 | -27.02% |
| October, 2025 | $5.2289 | $5.1579 | $7.9348 | -54.81% |
| November, 2025 | $8.573 | $3.811 | $7.413 | -25.90% |
| December, 2025 | $9.6982 | $8.4126 | $8.6682 | -16.18% |
Wave Life Sciences Ltd Stock (WVE) Price Forecast for 2026
The predicted value for Wave Life Sciences Ltd (WVE) in 2026 is set at an average of $7.2162. Estimates vary from a peak of $9.0129 to a trough of $5.4196, indicating an -37.63% surge from the present price of $11.57.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $7.2723 | $7.9023 | $8.7192 | -37.15% |
| February, 2026 | $7.8864 | $7.8143 | $7.1553 | -31.84% |
| March, 2026 | $6.9305 | $7.3205 | $7.1574 | -40.10% |
| April, 2026 | $5.6556 | $5.4196 | $5.9715 | -51.12% |
| May, 2026 | $5.5897 | $6.1197 | $5.4287 | -51.69% |
| June, 2026 | $9.0638 | $8.4507 | $9.0129 | -21.66% |
| July, 2026 | $8.7889 | $9.1748 | $8.8158 | -24.04% |
| August, 2026 | $7.523 | $8.033 | $7.8299 | -34.98% |
| September, 2026 | $7.4681 | $7.889 | $7.7471 | -35.45% |
| October, 2026 | $8.2922 | $7.9692 | $8.3712 | -28.33% |
| November, 2026 | $7.6663 | $8.0763 | $7.8205 | -33.74% |
| December, 2026 | $8.8015 | $7.8774 | $7.4404 | -23.93% |
Wave Life Sciences Ltd Stock (WVE) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Wave Life Sciences Ltd (WVE) is $8.7458, with a high forecast of $10.28 and a low forecast of $7.2107. This indicates an -24.41% decrease from the last price of $11.57.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $9.1256 | $8.8825 | $8.6935 | -21.13% |
| February, 2027 | $8.9197 | $8.7086 | $8.7666 | -22.91% |
| March, 2027 | $9.7748 | $9.2617 | $9.4848 | -15.52% |
| April, 2027 | $10.07 | $9.7468 | $9.8189 | -12.97% |
| May, 2027 | $10.11 | $10.36 | $10.28 | -12.59% |
| June, 2027 | $9.8481 | $9.7661 | $9.744 | -14.88% |
| July, 2027 | $9.9322 | $9.9512 | $9.7591 | -14.16% |
| August, 2027 | $9.7863 | $9.6553 | $9.7532 | -15.42% |
| September, 2027 | $9.9214 | $9.8273 | $10.14 | -14.25% |
| October, 2027 | $9.1955 | $9.3055 | $9.8425 | -20.52% |
| November, 2027 | $6.7496 | $7.8486 | $8.2566 | -41.66% |
| December, 2027 | $7.1348 | $7.2107 | $8.0937 | -38.33% |
Wave Life Sciences Ltd Stock (WVE) Price Forecast for 2028
In 2028, Wave Life Sciences Ltd (WVE) is projected to reach an average price of $5.3636, with a high projection of $7.3789 and a low estimate of $3.3483. This indicates an -53.64% fall from the last price of $11.57.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $7.5489 | $7.3458 | $7.3789 | -34.75% |
| February, 2028 | $6.553 | $6.723 | $7.0599 | -43.36% |
| March, 2028 | $5.0781 | $5.3381 | $5.854 | -56.11% |
| April, 2028 | $5.3922 | $5.4291 | $5.4412 | -53.40% |
| May, 2028 | $2.8273 | $4.5273 | $5.0842 | -75.56% |
| June, 2028 | $4.3414 | $3.3483 | $3.4315 | -62.48% |
| July, 2028 | $4.5155 | $4.0545 | $4.2524 | -60.97% |
| August, 2028 | $4.5706 | $4.5796 | $4.2406 | -60.50% |
| September, 2028 | $3.9147 | $4.0647 | $4.1477 | -66.16% |
| October, 2028 | $4.1088 | $3.9648 | $4.0538 | -64.49% |
| November, 2028 | $3.254 | $3.884 | $3.9499 | -71.88% |
| December, 2028 | $3.9281 | $3.7049 | $3.8081 | -66.05% |
Wave Life Sciences Ltd Stock (WVE) Price Forecast for 2029
The 2029 price forecast for Wave Life Sciences Ltd Stock (WVE) is $7.5541 on average, with a high prediction of $15.07 and a low estimate of $0.0383. This represents an -34.71% decrease from the previous price of $11.57.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $2.9032 | $3.1732 | $3.5691 | -74.91% |
| February, 2029 | $2.2973 | $2.8252 | $2.3463 | -80.14% |
| March, 2029 | $1.4014 | $2.2514 | $2.2393 | -87.89% |
| April, 2029 | $1.0155 | $1.0945 | $1.0924 | -91.22% |
| May, 2029 | $1.0206 | $1.0586 | $0.8786 | -91.18% |
| June, 2029 | $0.5247 | $0.7647 | $0.6937 | -95.46% |
| July, 2029 | $0.7488 | $0.9538 | $1.0568 | -93.53% |
| August, 2029 | $1.1839 | $0.8198 | $0.9089 | -89.77% |
| September, 2029 | $0.858 | $1.348 | $1.226 | -92.58% |
| October, 2029 | $0.7968 | $0.3401 | $2.5789 | -93.11% |
| November, 2029 | $0.1327 | $0.0773 | $1.4648 | -98.85% |
| December, 2029 | $16.17 | $0.0383 | $15.07 | +39.76% |
Wave Life Sciences Ltd Stock (WVE) Price Forecast for 2030
Wave Life Sciences Ltd Stock (WVE) is expected to reach an average price of $19.36 in 2030, with a high forecast of $30.99 and a low forecast of $7.7177. This signifies an +67.30% surge from the last price of $11.57.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $17.34 | $18.28 | $18.55 | +49.87% |
| February, 2030 | $16.35 | $17.29 | $15.53 | +41.30% |
| March, 2030 | $22.95 | $19.54 | $20.67 | +98.33% |
| April, 2030 | $18.66 | $20.40 | $20.11 | +61.32% |
| May, 2030 | $20.54 | $17.30 | $20.38 | +77.49% |
| June, 2030 | $17.32 | $20.00 | $20.46 | +49.68% |
| July, 2030 | $9.3886 | $11.90 | $14.41 | -18.85% |
| August, 2030 | $24.20 | $7.7177 | $17.79 | +109.18% |
| September, 2030 | $30.55 | $25.03 | $30.81 | +164.04% |
| October, 2030 | $30.40 | $30.83 | $30.99 | +162.71% |
| November, 2030 | $30.66 | $30.52 | $29.55 | +164.98% |
| December, 2030 | $29.34 | $29.00 | $28.02 | +153.60% |
3.95%
2.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):